These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17454031)

  • 1. Efficacy of rifabutin-loaded microspheres for treatment of Mycobacterium avium-infected macrophages and mice.
    Barrow EL; Barrow WW; Quenelle DC; Westbrook L; Winchester GA; Staas JK
    Drug Deliv; 2007 Mar; 14(3):119-27. PubMed ID: 17454031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic implications of nano-encapsulated rifabutin, azithromycin & ethambutol against experimental
    Grewal TK; Majeed S; Sharma S
    Indian J Med Res; 2018 Jun; 147(6):594-602. PubMed ID: 30168492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium.
    Bermudez LE; Inderlied CB; Kolonoski P; Petrofsky M; Aralar P; Wu M; Young LS
    Antimicrob Agents Chemother; 2001 Jan; 45(1):217-22. PubMed ID: 11120969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of repeated rifabutin administration on the pharmacokinetics of intravenous and oral ciprofloxacin in mice.
    Liu XG; Li RC
    J Chemother; 2001 Oct; 13(5):563-8. PubMed ID: 11760222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimycobacterial synergism of clarithromycin and rifabutin.
    Ghebremichael S; Svenson SB; Källenius G; Hoffner SE
    Scand J Infect Dis; 1996; 28(4):387-90. PubMed ID: 8893404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clarithromycin or rifabutin alone or in combination for primary prophylaxis of Mycobacterium avium complex disease in patients with AIDS: A randomized, double-blind, placebo-controlled trial. The AIDS Clinical Trials Group 196/Terry Beirn Community Programs for Clinical Research on AIDS 009 Protocol Team.
    Benson CA; Williams PL; Cohn DL; Becker S; Hojczyk P; Nevin T; Korvick JA; Heifets L; Child CC; Lederman MM; Reichman RC; Powderly WG; Notario GF; Wynne BA; Hafner R
    J Infect Dis; 2000 Apr; 181(4):1289-97. PubMed ID: 10762562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of microsphere technology for targeted delivery of rifampin to Mycobacterium tuberculosis-infected macrophages.
    Barrow EL; Winchester GA; Staas JK; Quenelle DC; Barrow WW
    Antimicrob Agents Chemother; 1998 Oct; 42(10):2682-9. PubMed ID: 9756777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel ceftazidime/avibactam, rifabutin, tedizolid and moxifloxacin (CARTM) regimen for pulmonary Mycobacterium avium disease.
    Deshpande D; Srivastava S; Pasipanodya JG; Lee PS; Gumbo T
    J Antimicrob Chemother; 2017 Sep; 72(suppl_2):i48-i53. PubMed ID: 28922809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of rifabutin, clarithromycin, ethambutol, sparfloxacin and amikacin, alone and in combination, against Mycobacterium avium complex in human macrophages.
    Pellegrin I; Maugein J; Lapeyre C; Barbeau P; Leng B; Pellegrin JL
    J Antimicrob Chemother; 1996 Mar; 37(3):501-10. PubMed ID: 9182107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Susceptibility to rifabutin and novel fluoroquinolones in Mycobacterium avium complex isolates from patients with sputum culture-positive pulmonary disease who are undergoing standard chemotherapy].
    Tateishi Y; Motone M; Yoshimura K; Miki M; Miki K; Kitada S; Hashimoto H; Hiraga T; Maekura R
    Nihon Kokyuki Gakkai Zasshi; 2010 Nov; 48(11):797-802. PubMed ID: 21141056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. California Collaborative Treatment Group.
    Havlir DV; Dubé MP; Sattler FR; Forthal DN; Kemper CA; Dunne MW; Parenti DM; Lavelle JP; White AC; Witt MD; Bozzette SA; McCutchan JA
    N Engl J Med; 1996 Aug; 335(6):392-8. PubMed ID: 8676932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in vivo activities of rifabutin and rifapentine against Mycobacterium avium complex.
    Klemens SP; Grossi MA; Cynamon MH
    Antimicrob Agents Chemother; 1994 Feb; 38(2):234-7. PubMed ID: 8192449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic drug monitoring in the treatment of Mycobacterium avium complex lung disease.
    Koh WJ; Jeong BH; Jeon K; Lee SY; Shin SJ
    Am J Respir Crit Care Med; 2012 Oct; 186(8):797-802. PubMed ID: 22878282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of KRM 1648 or rifabutin alone or in combination with clarithromycin against Mycobacterium avium complex in human alveolar macrophages.
    Suzuki K; Tsuyuguchi K; Matsumoto H; Yamamoto T; Hashimoto T; Tanaka E; Amitani R; Kuze F
    Int J Tuberc Lung Dis; 1997 Oct; 1(5):460-7. PubMed ID: 9441102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of azithromycin and rifabutin in preventing infection by Mycobacterium avium complex in beige mice.
    Bermudez LE; Petrofsky M; Inderlied CB; Young LS
    J Antimicrob Chemother; 1995 Oct; 36(4):641-6. PubMed ID: 8591938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Mono Mac 6 human monocytic cell line and J774 murine macrophage cell line in parallel antimycobacterial drug studies.
    Wright EL; Quenelle DC; Suling WJ; Barrow WW
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2206-8. PubMed ID: 8878609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic efficacy of liposomal rifabutin in a Mycobacterium avium model of infection.
    Gaspar MM; Neves S; Portaels F; Pedrosa J; Silva MT; Cruz ME
    Antimicrob Agents Chemother; 2000 Sep; 44(9):2424-30. PubMed ID: 10952590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activities of clarithromycin, sulfisoxazole, and rifabutin against Mycobacterium avium complex multiplication within human macrophages.
    Perronne C; Gikas A; Truffot-Pernot C; Grosset J; Pocidalo JJ; Vilde JL
    Antimicrob Agents Chemother; 1990 Aug; 34(8):1508-11. PubMed ID: 2171421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of rifabutin on the phagocytosis and intracellular growth of Mycobacterium intracellulare in mouse resident and activated peritoneal and alveolar macrophages.
    Perumal VK; Gangadharam PR; Iseman MD
    Am Rev Respir Dis; 1987 Aug; 136(2):334-7. PubMed ID: 3039880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Killing by antimycobacterial agents of AIDS-derived strains of Mycobacterium avium complex inside cells of the mouse macrophage cell line J774.
    Yajko DM; Nassos PS; Sanders CA; Hadley WK
    Am Rev Respir Dis; 1989 Nov; 140(5):1198-203. PubMed ID: 2817581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.